| 0
Author's PhotoUpload Author Photo
Front CoverUpload Front Cover
Back CoverUpload Back Cover
Author's Brief Bio

T.S.Aguilar began writing in earnest in the 1990s. He met his wife, a film maker, at that time when he worked on film scripts and together they produced several documentaries on health issues and an archaeological dig. They ventured into teaching in Mexico, Oman, the United Arab Emirates, and Saudi Arabia. When his wife was stricken with cancer, they returned to Canada. His wife encouraged him to write his novels "Impetuous - The Odyssey of a Solitary Man" and "Shafted - A Mexican Tale". Both novels are based on personal experience and have received five star reviews from BookViral Reviews (UK) describing them as "a power-packed thriller where the pace rarely wanes" and "a high octane whiz-bang of a read that proves to be another powerful release by Aguilar", respectively. Yet, his quite possibly most important work was still to come. It is the literary non-fiction work "Lifeline - The Case for Effective Cancer Immunotherapy". When his wife struggled with cancer and wilted away due to negligent treatment, Aguilar researched current cancer treatments and searched for a cure for his wife. When she succumbed to the disease, he collated the information and wrote his book that has received yet another five star review from BookViral Reviews.

Book Description (Synopsis)

The book “Lifeline” provides a detailed review of a cancer case history, the failures of conventional cancer treatment that results in the death of close to 10 million “effectively treated” patients globally every year, and the research and development of various types of cancer immunotherapy, which is the only hope we have to provide a cure for the disease.

Book Front Cover Designer


Back Cover Description

The back cover provides an overview of what is addressed with the book. The focus is on immunotherapy and the work of scientists of different disciplines researching formulas and methods to strengthen the human immune system with the goal of eliminating cancer cells and tumours without side effects. It includes a plea for global immunotherapy research cooperation. Briefly mentioning the author's work to date, his research of the book's topic, and his photo concludes the back cover description.

Author's Book Dedication

The book was written in memory of my late wife Cathy (1963 - 2017). May her valiant struggle not have been in vain, so that her story will help other cancer patients to get effective treatment and be cured of the disease.

Story Keywords

Cancer case history, cancer treatment, immunotherapy

Estimated Word Count


Book Completion Date



It is a fantastic book!
Dr. C. Friesen - microbiological researcher specialised in oncology

The remarkably lively written book is clear and perceptive about the current situation and the prospects of cancer treatment. For someone like me who works in the field, it is a great pleasure to see what I experience every day written about in a well-founded manner.
Dr. H.J. Hilscher - Palliative Care Specialist

This is an effective treatise on cancer treatment, written in a coherent and non-technical way.
G. Bancroft, Oxford, UK

Support Assistants with Titles
Team Member Editor
Advertising Hook

Lifeline – The Case for Effective Cancer Immunotherapy is unreservedly recommended for anyone wanting to further their understanding of cancer treatments.



Contest Manuscript Details

The Case for Effective Cancer Immunotherapy


Copyright © 2020: T.S.Aguilar

Table of Contents

Preamble 1

Cathy’s Case History 5
Suddenly and Unexpected... 8
The First Misdiagnosis 10
A Meticulous Exam 11
Devastating News 12
Gaining an Insight is a Slow Process 13
The Second and Decisive Misdiagnosis 17
Emergency Measures 19
The Continued Search for the Cause 22
The Ups and Downs of Treatment 25
First Mention of ‘Palliative Care’ 27
A Second Opinion and Hope at Last 30
When Something Sounds Too Good to be True... 35
And onto a Slippery Slope We Went 37
Palliative Care - The First 41
“Fun and Games” in Canada 44
Once More Back “Home” 50
Back in our Old Haunt 55
On Home Turf to the Bitter End 59
Palliative Care - The Second 64
The Final Days 72
Aftermath 77

Current Cancer Treatment and its Repercussions 83
No Cure for Cancer - Yet 86
The Need for a New Approach 97
A Big Hurdle Looms 98
A Conspiracy of Silence 105
Killing for Profit? 107
New Cancer Drugs - Expensive and Mostly Useless 111
An Investigation of Corruption and Fraud 118
Corruption and Fraud is Widespread 121
The Media Needs to Differentiate 126
Palliative & Hospice Care 129
One Crisis Noted - Another Practically Ignored 134
Cancer and the ‘Health Service Industry’ 139
Same Old, Same Old... 141

What is the Future of Cancer Treatment? 143
You Are What You Eat 145
Ignored Orphan Medications 151
Could D,L-Methadone be the Answer? 156
An Unconventional Cancer Therapy 165
Thinking Outside the Box 166
A Look at Immunotherapy 169
The White Blood Cell Phenomenon 175
Immunotherapies in Use Today 181
What’s New, Doc? 186
CRISPR - Not a New Potato Chip 188
Cold Plasma Cancer Immunotherapy 190
Immunotherapy: An Old Hat? 195
Cancer Vaccine - Not A Dream Any Longer 197
The Outlook for Immunotherapy 200

A Few Words of Encouragement 204

Appendix of Recommended Additional Reading 207

The D,L-methadone aqueous solution recipe 210

The book begins with a preamble that sets the tone of the work and provides the reader with an introduction of the entire work.

First of all I advise every reader that this book should not be construed as medical advice - repeat - it is not medical advice for cancer treatment. It does not propagate a miraculous cure or suggest consulting soothsayers who claim to have cured thousands of terminally ill cancer patients. It presents an incisive look at current cancer treatment, what is wrong with it, and the ongoing research and development of immunotherapies that provide a ray of hope for a cancer cure in the near future.
Now you may well ask what moves a guy without medical training to write about cancer, one of the most complex diseases to befall humanity. It started as a therapy of writing down my wife Cathy’s case history of struggling with the disease, which to a large extent was based on her meticulous diary entries, and my concurrent search for a cure. My wife succumbed to cancer after a nineteen-month struggle to get the treatment that could have prolonged her life and in the best case cured her. The story is probably familiar to most families and caregivers who have lost a loved one to the disease and is equally familiar to the millions of patients searching and hoping for a cure.
While I continued researching current cancer treatments, therapies, and medications, the inconsistencies of treatment as well as the failure of prescribed and administered therapies and medications to have any curative effect became apparent. Hence and not just by chance, Big Pharma’s allegedly “effective” therapies came into focus that result almost nine million cancer deaths globally a year. There is practically no cure for cancer at present because the eight and a half million “survivors” have on average up to about five years of progression free survival before the cancer recurs in a more aggressive form and death.
My research also shed light on malpractice and corruptibility of institutes and practitioners as well as the media’s promotion of alleged advances in conventional cancer treatment.
The negative and depressing outcome of the research of current cancer treatment moved me to search for new and unconventional treatments and medications and concluded with an investigation of curative therapies that provide hope for all people afflicted with cancer, directly and indirectly. The outcome was what I call the case for effective immunotherapy to heal patients of their cancer.
It resulted in a positive outlook that should give hope to all people diagnosed with cancer to be cured of the disease for good in the foreseeable future. It is still a long way to go and the scientists and researchers will want to learn much more about cancer and the immune system before a great and ultimate medical breakthrough will be achieved. The good news is that there is indeed light at the end of the tunnel and by all accounts it is not an oncoming train.
The critical wording describing dithering medics and useless therapies may look like a condemnation of the health care systems of the two countries where my wife was diagnosed and ultimately failed to be treated effectively. But it is not! The health care systems of most other countries are not any better and in many cases far worse. It doesn’t matter if a health care system is public or private, universal or based on individual health insurance policies. All of them are inadequate to provide effective curative cancer treatments and prevent the deaths of millions of patients.
Several hurdles will have to be taken to improve health care. Among them are better work conditions and salaries of health care workers to attract more young people into these professions and alleviate present day shortages, increased financing of immunotherapy research and development, overcoming the bureaucracy that refuses to accept researchers' trial results as relevant, as well as Big Pharma’s lack of interest in and its active hindrance of finding and implementing a cancer cure.
I trust that the health care operators as well as governments on the whole will take the criticisms to heart and recognise the positive pointers.
The epidemics and pandemics of the recent past have confirmed the aforementioned inadequacies of current health care policies. It begs the question if any country needs more bureaucrats to administer its health care system than medical practitioners and yet at salaries that would make nurses swoon with happiness if they received the bureaucrats’ remuneration in recognition of their work.
Politicians of all stripes should agree to raise the health care budgets instead of slashing them and provide a well-functioning, comprehensive universal health care. It has to include dental, ocular, and auditory treatments needed mainly by old people who are also the age group most vulnerable to cancer. It has to be recognised that only a population whose health care for everybody is assured without driving them into bankruptcy and poverty can achieve a level of happiness they deserve and be fully productive.
Governments should restrain their bureaucracy, promote and support medical research and development at universities, and stop whining about how much health care costs. Instead they should consider it an investment into productivity and social cohesion that is lost due to the lack of effective care for the sick and elderly.
In short, the book is a summary of my multi-year investigation of medical practice, the health care industry, and Big Pharma. It is a critical assessment of conventional cancer treatments based on my experience as caregiver of both my mother and my wife who were diagnosed with and succumbed to cancer. It concludes with insights into the research of various techniques and therapies that enhance immunotherapy, the manipulation and strengthening of the human immune system, and its facilitation to eradicate cancer cells without side effects.
Thus, writing this essay was like passing through a dark valley of death into the glimmer of hope of a new day.

After the preamble follows the case history of my wife's treatment, the misdiagnoses, the negligent treatment, and the questionable (potentially criminal) administration of fentanyl in the hospice that resulted in her death. It uncovers the blatant lies told by almost every medical practitioner about the availability of adjunct and adjuvant medications that could have provided a life extension, if not a cure. In support of the author's claim, doctors are quoted and reports are cited about the failing health care systems.

Next is an extensive review of conventional cancer therapies. In relation to the current treatments, the corruption and corruptibility of medical practitioners is cited, the media is lambasted for its subservient role in support of the pharmaceutical industry, and big pharma is condemned for its pricing policies of definitely non-curative and mostly useless cancer medication.

Finally, light is shed on the research and promising success to date of cancer immunotherapy. The work involved in the development of these therapies is explained as well as the different types of therapies, the function of the white blood cells, and the research that lies ahead until a broad spectrum medication for all types of cancer will be available at a reasonable price to the general public of cancer sufferers.

The work concludes with words of encouragement for people diagnosed with cancer and a list of questions to ask an oncologist as well as a list of additional reading.